Finally - Available Now in 2025 at AGE METRICS in Costa Rica

🧬 Norditropin's Supply Rollercoaster

Norditropin Back In Stock

Out of Stock: Post‑Covid Years

Restocking: Mid‑2025

Shortly after the peak of the COVID‑19 pandemic, Novo Nordisk confronted “lower-than-anticipated output” from its growth‑hormone production lines. That, coupled with pandemic-driven supply chain snarls, created a perfect storm. As the company candidly stated in a December 2023 supply update:

“Novo Nordisk continues to experience supply constraints of Norditropin … exacerbated by … delays for production and batch release.” Reuters+6norditropin.com+6drugshortagescanada.ca+6

By November 2022, reports flagged it as facing a long-term backorder with no release date in sight ASHP. ASHP updated the shortage status as of June 4, 2025, confirming Norditropin (30 mg pens) remained on extended backorder—demand was up and production lagged ASHP+1ASHP+1.

Yet, a positive shift emerged: Novo Nordisk’s March 2024 update signaled prioritization of 10 mg and 15 mg pens—aiming to stabilize supply by late 2024 norditropin.com+1norditropin.com+1. This groundwork resulted in slightly improved availability entering 2025. By mid‑2025, multiple pharmacies began reporting renewed access, marking a meaningful restock milestone.

Corporate Transparency & Shortage Policy

Novo Nordisk embraced a policy of regular, transparent updates. In their quarterly supply bulletins, they noted:

  • Immediate causes: manufacturing interruptions, lead-time delays.

  • Mitigations underway: optimizing current lines, building new plants, and increasing fill-finish investments Reuters+2norditropin.com+2Novo Nordisk+2.

These updates reflect their commitment to clear communication—alerting prescribers and patients when constraints persist and offering guidance on alternative strengths or brands.

Similar Supply Snarls: Ozempic & Wegovy

Norditropin’s challenges were far from isolated:

Ozempic® (semaglutide for T2D)

  • Novo Nordisk warned of “periodic supply constraints” in early 2023 due to skyrocketing demand and tighter manufacturing capabilities norditropin.comReuters.

  • Though U.S. supply stabilized, certain international markets continued to struggle.

Wegovy® (semaglutide for obesity)

  • Wegovy saw serious global shortages in 2022–2023, leading to rationing. Supply normalized in the U.S. only by December 2023 Reuters+1en.wikipedia.org+1.

Broader GLP‑1 Crunch

  • Semaglutide shortages persisted; in April 2024, Novo Nordisk disclosed round‑the‑clock production measures and a $6 billion investment to tame the demand surge .

What This Means for Patients

  • Provider guidance: During Norditropin’s shortage, physicians turned to alternatives like Merck’s Saizen, Pfizer’s Genotropin or Sandoz’s Omnitrope ASHP.

  • Patient strategies: Novo Nordisk advised discussing alternative pen strengths or drug options with providers norditropin.com+2norditropin.com+2drugshortagescanada.ca+2.

Looking Ahead

Novo Nordisk’s approach—frequent public supply updates, admission of constraints, and investment in new capacity—represents a more community-oriented model. However, the company cautions that intermittent shortages may still occur as they scale up production.


Summary Table

MedicationShortage PeriodRoot CausesCurrent Status (mid‑2025)
Norditropin HGHLate 2022 – mid‑2025Production delays, backlog in manufacturingStock returning (10 mg/15 mg pens)
Ozempic2022 – 2023Demand surge, manufacturing limitsImproved in U.S.; some global constraints
Wegovy2022 – late 2023High demand, supply-chain limitsReplenished by late 2023 in U.S.

Bottom Line

Norditropin is officially back in stock as of mid‑2025, albeit gradually—most reliably in key strengths. Novo Nordisk’s transparent shortage policy, with open updates and contingency plans, is a welcome step. But it’s a reminder: no biologic is immune to global production pressures. Patients and providers should remain vigilant, and stay informed through official communications and their pharmacists.


Sources: ASHP/Drug Information Service, ASHP drug shortage bulletins ; Novo Nordisk supply updates and investor reports .

Flying with Growth Hormone (HGH) Pens

Before your trip, we recommend bringing a soft-case 6-pack cooler, as it’s the perfect size to safely store Norditropin or Merck Saizen HGH pen boxes and cartridges along with cool packs. You can either purchase the cool packs from us or bring your own from home when you visit our treatment center.

HGH Medical Cooler for Travel
Example Nylon Standard 6-Pack Cooler
Norditropin HGH Pens in your luggage.
Cool Pack with Norditropin Pens

A standard six-pack cooler like the one made by Ozark Trail is an excellent option. These coolers can be purchased at Walmart for around $10. You will find them located in the sporting goods area of the store. Online Ozark Trail Cooler Link Walmart. You can fit approximately 20 pens in the cooler with ICE packs.

Secure Your Cooler in Your Checked Baggage or Carry on Baggage

Passanger with 36" Suitcase
36" Roller Bag Suitcase with Cooler Inside

Place your Norditropin Travel Letter and Prescription in the Cooler with Your Medication

Place your doctor’s prescription and your Norditropin TSA travel letter inside the cooler on top in case your luggage is randomly searched by TSA or border security. Remember, it is legal to travel with a reasonable amount of personal use medication. You should have no problems whatsoever traveling to most countries throughout the world with your treatment. The important thing to remember is keep your prescription and travel form secured with your medication.

Additional Tips

  • Keep your luggage locked with a standard TSA travel lock.
  • Keep an extra copy of your prescription and TSA travel letter on your person as well, just in case.
  • Always keep a copy of your TSA travel letter inside your cooler with your medication.

Since 2013, we’ve successfully treated thousands of patients from around the world. We’ve never had a problem with them traveling with their personal use medications if they follow border security and TSA rules.